← Back to Clinical Trials
Recruiting NCT07572942

NCT07572942 Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07572942
Status Recruiting
Phase
Sponsor Balikesir University
Condition Motoric Cognitive Risk Syndrome
Study Type OBSERVATIONAL
Enrollment 35 participants
Start Date 2026-04-15
Primary Completion 2026-04-28

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 35 participants in total. It began in 2026-04-15 with a primary completion date of 2026-04-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the validity and reliability of neuroscience-based visual laser feedback map tests in individuals with Motoric Cognitive Risk Syndrome (MCRS). The developed assessment protocol integrates visuospatial processing, reaction time, and upper extremity motor control within a single task. Construct validity will be examined through correlations with reaction time and proprioception measurements, and test-retest reliability will be assessed to determine measurement consistency.

Eligibility Criteria

Inclusion Criteria: Aged ≥65 years Diagnosis of Motoric Cognitive Risk Syndrome (subjective cognitive complaint + slow gait) Living independently in the community Able to understand and perform test procedures Exclusion Criteria: Diagnosed dementia Severe psychiatric disorders Advanced visual impairments (e.g., macular degeneration, severe cataract) Neurological disorders affecting motor control Severe tremor or ataxia interfering with task performance

Contact & Investigator

Central Contact

Ebru Tekin, Lecturer

✉ ebrutekin123@gmail.com

📞 +90 266 614 69 11

Frequently Asked Questions

Who can join the NCT07572942 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Motoric Cognitive Risk Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07572942 currently recruiting?

Yes, NCT07572942 is actively recruiting participants. Contact the research team at ebrutekin123@gmail.com for enrollment information.

Where is the NCT07572942 trial being conducted?

This trial is being conducted at Balıkesir, Turkey (Türkiye).

Who is sponsoring the NCT07572942 clinical trial?

NCT07572942 is sponsored by Balikesir University. The trial plans to enroll 35 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology